Collectively, our data suggest that ephrinB2 loss promotes tumour invasion by increasing the intrinsic invasive capacity and by permitting the invasion into the EphB2/EphB4 expressing parenchyma through avoiding repulsive interactions, thereby reducing tumour compartmentalization. The gene discussed is EFNB2; the disease is neoplasm.